Ironwood Pharmaceuticals | IRWD - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Akebia Therapeutics USD 427M 297M 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.48B 63M 2026-03
Astellas Pharma JPY 4.1T 160.64B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Charles River Laboratories USD 13.33B 2.94B 2026-08
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Incyte USD 26.84B 4.19B 2026-08
Karyopharm Therapeutics USD 221M 95M 2026-08
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 184M 82M 2026-03
Pacira USD 1.28B 286M 2026-08
Sarepta Therapeutics USD 1.5B 402M 2026-08
Takeda JPY 8.2T 809.7B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vanda Pharmaceuticals USD 279M 6M 2024-12